Mendel therapeutics is a Brno, Czech Republic, based company focused on the development of better Vaccines, Immunomodulators and Drug delivery systems. The company is the result of the long-term, successful collaboration of its principal founders. ImuThes Ltd, London, Institute of Organic Chemistry and Biochemistry (IOCB), Prague , Veterinary Research Institute (VRI), Brno, and Life Sciences Capital (LSC).
Mucosal Vaccines
(flu, other)
Therapeutic Vaccines
(cancer, other)
Immunomodulation
Wound healing
APRIL 09
Formal establishment of company and opening of research centers in Prague and Brno.
MARCH 09
PCT application on novel adjuvants and immunomodulators.
JANUARY 09
IOCB, VRI, ImuThes, and LSC agree to establish Mendel Therapeutics by contributing patented compounds, know-how and start-up management skills to the new venture.